Concentrix (NASDAQ:CNXC) & Phreesia (NYSE:PHR) Head to Head Survey

Phreesia (NYSE:PHR) and Concentrix (NASDAQ:CNXC) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

Volatility & Risk

Phreesia has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, Concentrix has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500.

Insider & Institutional Ownership

92.1% of Phreesia shares are held by institutional investors. Comparatively, 90.3% of Concentrix shares are held by institutional investors. 5.8% of Phreesia shares are held by company insiders. Comparatively, 3.2% of Concentrix shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Phreesia and Concentrix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Phreesia	-20.43%	-32.78%	-22.37%
Concentrix	2.61%	16.67%	5.63%

Analyst Ratings

This is a summary of current recommendations for Phreesia and Concentrix, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	0	0	12	0	3.00
Concentrix	0	1	4	1	3.00

Phreesia presently has a consensus target price of $31.33, suggesting a potential upside of 31.32%. Concentrix has a consensus target price of $69.60, suggesting a potential upside of 46.68%. Given Concentrix’s higher probable upside, analysts clearly believe Concentrix is more favorable than Phreesia.

Valuation & Earnings

This table compares Phreesia and Concentrix”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$419.81 million	3.34	-$136.88 million	($1.02)	-23.39
Concentrix	$9.59 billion	0.32	$251.22 million	$3.99	11.89

Concentrix has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than Concentrix, indicating that it is currently the more affordable of the two stocks.

Summary

Concentrix beats Phreesia on 9 of the 14 factors compared between the two stocks.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

About Concentrix

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications. It also offers customer lifecycle management; customer experience/user experience strategy and design; analytics and actionable insights; digital transformation services that design and engineer CX solutions to enable efficient customer self-service and build customer loyalty; customer engagement solutions and services that address the entirety of the customer lifecycle; AI technology that can intelligently act on customer intent to improve customer experience with non-human engagement; voice of the customer and analytics solutions to gather and analyze customer feedback to foster loyalty to, and growth with, clients; analytics and consulting solutions that synthesize data and provide professional insight to improve clients’ customer experience strategies; vertical business process outsourcing (BPO) services; and back office BPO services that support clients in non-customer facing areas. The company’s clients include technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, healthcare, and others, as well as global IPOs, social brands, and banks. Concentrix Corporation was founded in 2004 and is based in Newark, California.